American International Group’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-40,935
Closed -$275K 598
2024
Q1
$275K Sell
40,935
-353
-0.9% -$2.18K ﹤0.01% 1963
2023
Q4
$243K Buy
41,288
+814
+2% +$6.24K ﹤0.01% 2073
2023
Q3
$395K Buy
40,474
+7,286
+22% +$86.4K ﹤0.01% 1733
2023
Q2
$393K Buy
33,188
+2,291
+7% +$26.3K ﹤0.01% 1799
2023
Q1
$333K Buy
30,897
+615
+2% +$7.87K ﹤0.01% 1826
2022
Q4
$350K Sell
30,282
-110
-0.4% -$1.36K ﹤0.01% 1797
2022
Q3
$453K Buy
30,392
+9,515
+46% +$130K ﹤0.01% 1640
2022
Q2
$188K Buy
20,877
+2,429
+13% +$16.6K ﹤0.01% 2220
2022
Q1
$138K Sell
18,448
-1,298
-7% -$9.04K ﹤0.01% 2454
2021
Q4
$169K Sell
19,746
-591
-3% -$5.14K ﹤0.01% 2461
2021
Q3
$171K Sell
20,337
-483
-2% -$3.7K ﹤0.01% 2516
2021
Q2
$169 Buy
+20,820
New +$176K ﹤0.01% 2615
2019
Q2
Sell
-3,073
Closed -$54K 3113
2019
Q1
$54K Sell
3,073
-60
-2% -$1.03K ﹤0.01% 2851
2018
Q4
$55K Buy
3,133
+2,545
+433% +$75.3K ﹤0.01% 2851
2018
Q3
$24K Buy
588
+11
+2% +$620 ﹤0.01% 3123
2018
Q2
$33K Buy
+577
New +$27.7K ﹤0.01% 3029

Other funds holding COGT

American International Group's COGT Position: Q2 2024 in Review

American International Group sold out of Cogent Biosciences (COGT) in Q2 2024, closing a stake of 40,935 shares — an estimated $275K sold.

American International Group first reported a position in COGT in Q2 2018 and held it in 16 quarters. The position peaked at $453K in Q3 2022. 148 funds tracked by Wall St. Rank hold COGT as of Q2 2024.

  • American International Group reported no remaining Cogent Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 40,935 Cogent Biosciences shares in Q2 2024, an estimated $275K.
  • American International Group first reported a position in Cogent Biosciences in Q2 2018 and held it in 16 quarters.
  • American International Group's Cogent Biosciences position peaked at $453K in Q3 2022.
  • 148 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.